---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-008381"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2022-06-15T23:59:59+00:00"
generated_at: "2026-06-25T01:38:39.640994+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zomedica appoints Anthony K. Blair as COO and Karen DeHaan-Fullerton as Chief Counsel

## Summary
- Anthony K. Blair appointed COO effective June 13, 2022; base salary $250K with up to 35% annual performance bonus.
- Karen DeHaan-Fullerton appointed Chief Counsel and Corporate Secretary; base salary $250K with up to 30% annual bonus.
- Blair previously EVP Operations since Jan 2022; prior roles include COO of Cardiox and VP at Neoprobe.
- DeHaan-Fullerton had been General Counsel since May 2022; prior experience at Exactech and Elanco.
- Both retain previously granted stock options (Blair: 3M shares at $0.35; DeHaan-Fullerton: 500K at $0.24) with four-year vesting.

## SEC filing metadata
- accession: 0001654954-22-008381
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2022-06-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495422008381/0001654954-22-008381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495422008381/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-008381
- JSON: https://secwatch.observer/filing/0001654954-22-008381.json
- Plain text: https://secwatch.observer/filing/0001654954-22-008381.txt

## Key facts
- Executive change
  Karen DeHaan-Fullerton was appointed as Chief Counsel and Corporate Secretary at Zomedica Corp..
  - Action: appointed
  - Role: Chief Counsel and Corporate Secretary
  source text: On June 13, 2022, the Company appointed Karen DeHaan-Fullerton as the Company’s Chief Counsel and Corporate Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000165495422008381/0001654954-22-008381-index.htm
- Executive change
  Anthony K. Blair was appointed as Chief Operating Officer at Zomedica Corp..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On June 13, 2022, Zomedica Corp. (the “Company”) appointed Anthony K. Blair as the Company’s Chief Operating Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000165495422008381/0001654954-22-008381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.